Phosphotyrosine signaling analysis of site-specific mutations on EGFRvIII identifies determinants governing glioblastoma cell growth
Paul H. Huang(Institute of Cancer Research), Forest M. White(Center for Cancer Research), Vibin A. Kundukulam(Massachusetts Institute of Technology), Frank B. Furnari(University of California San Diego), Alexander M. Xu(Cedars-Sinai Medical Center), Webster K. Cavenee(University of California San Diego), Amanda Del Rosario(Massachusetts Institute of Technology), Ryan A. Flynn(Boston Children's Hospital), Emily R. Miraldi(Cincinnati Children's Hospital Medical Center)
Cited by 46
Related Papers
Malignant astrocytic glioma: genetics, biology, and paths to treatment
|Genes & Development|2007|2.3k
The WHO Classification of Tumors of the Nervous System
|Journal of Neuropathology & Experimental Neurology|2002|2k
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
|Nature Biotechnology|2002|1.6k
Molecular Determinants of the Response of Glioblastomas to EGFR Kinase Inhibitors
|New England Journal of Medicine|2005|1.4k
How many human proteoforms are there?
|Nature Chemical Biology|2018|945